8200.0000 -58.50 (-0.71%)
NSE May 27, 2026 10:15 AM
Volume: 39,752
 

8200.00
-0.71%
Prabhudas Lilladhar
to ensure non-compete and synergy alignment between AHEL and NewCo, with clear role demarcation - AHEL to focus on core healthcare and NewCo on pharmacy & digital. The demerger was on expected lines and is aimed to unlock value by creating a focused, high-growth platform in the pharmacy and digital healthcare space, which is more consumer centric in nature. The stake sale in HealthCo to Advent and merger with Keimed are a positive step and will lead to an integrated pharmacy distribution business. Scale-up in...
Apollo Hospitals Enterprise Ltd. is trading above all available SMAs
More from Apollo Hospitals Enterprise Ltd.
Recommended